Company profile

Ticker
HWKN
Exchange
CEO
Patrick H. Hawkins
Employees
Incorporated in
Location
Fiscal year end
Former names
Hawkins Chemical Inc
SEC CIK
IRS number
410771293

HWKN stock data

(
)

Calendar

30 Oct 19
14 Dec 19
29 Mar 20

News

Company financial data Financial data

Quarter (USD) Sep 19 Jun 19 Mar 19 Dec 18
Revenue 140.04M 147.34M 133.05M 128.15M
Net income 9.25M 9.81M 3.77M 4.13M
Diluted EPS 0.87 0.92 0.35 0.39
Net profit margin 6.61% 6.66% 2.83% 3.22%
Operating income 13.18M 13.96M 5.79M 6.72M
Net change in cash -1.55M -3.59M 1.9M 3.26M
Cash on hand 4.06M 5.61M 9.2M 7.3M
Cost of revenue 112.05M 118.54M 112.38M 107.12M
Annual (USD) Mar 19 Mar 15
Revenue 556.33M 364.02M
Net income 24.43M 19.21M
Diluted EPS 2.28 1.81
Net profit margin 4.39% 5.28%
Operating income 36.82M 30.42M
Net change in cash -9.44M
Cash on hand 9.2M 18.64M
Cost of revenue 460.39M 298.23M

Financial data from Hawkins earnings reports

Financial report summary

?
Risks
  • Environmental problems at any of our facilities could result in significant unexpected costs.
  • Our food, pharmaceutical and nutritional products are subject to government regulation, both in the United States and abroad, which could increase our costs significantly and limit or prevent the sale of such products.
  • Our businesses expose us to potential product liability claims and recalls, which could adversely affect our financial condition and performance.
  • Demand for our food and nutritional products is highly dependent upon consumers’ perception of the safety and quality of our products, our customers’ products as well as similar products distributed by other companies, and adverse publicity and negative public perception regarding particular ingredients or products or the nutraceuticals industry in general could limit our ability to increase revenue and grow that portion of our business.
  • The insurance that we maintain may not fully cover all potential exposures.
  • Failure to comply with the covenants under our credit facility may have a material adverse effect.
  • Impairment to the carrying value of our goodwill or other intangible assets could adversely affect our financial condition and consolidated results of operations.
Management Discussion
  • We derive substantially all of our revenues from the sale of chemicals and specialty ingredients to our customers in a wide variety of industries. We began our operations primarily as a distributor of bulk chemicals with a strong customer focus. Over the years, we have maintained the strong customer focus and have expanded our business by increasing our sales of value-added chemical and specialty ingredients, including manufacturing, blending, and repackaging certain products.
  • We focus on total profitability dollars when evaluating our financial results as opposed to profitability as a percentage of sales, as sales dollars tend to fluctuate, particularly in our Industrial and Water Treatment segments, as raw material costs rise and fall. The costs for certain of our raw materials can rise or fall rapidly, causing fluctuations in gross profit as a percentage of sales.
  • We use the last in, first out (“LIFO”) method for valuing the majority of our inventory in our Industrial and Water Treatment segments, which causes the most recent product costs for those products to be recognized in our income statement. The valuation of LIFO inventory for interim periods is based on our estimates of fiscal year-end inventory levels and costs. The LIFO inventory valuation method and the resulting cost of sales are consistent with our business practices of pricing to current chemical raw material prices. Inventories in the Health and Nutrition segment are valued using the first in, first out (“FIFO”) method.
Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Good
New words: announced, doubtful, percent, removed
Removed: August, established, expire, partially